Allogene Therapeutics Inc (ALLO)

Capital Lease Obligations

$70.35M

Quarterly · Period ending: · USD

ALLO logo

ALLO Capital Lease Obligations

Latest reported$70.35M
ALLO Quarterly Capital Lease Obligations ($0.00 → $70.35M)
High-resolution chart · PNG

ALLO capital lease obligations history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Allogene Therapeutics Inc Capital Lease Obligations — Quarterly (USD)
Period endingCapital Lease Obligations (USD)
70,353,000
72,633,000
83,253,000
77,134,000
79,241,000
81,292,000
90,756,000
85,135,000
86,989,000
88,916,000
95,121,000
90,102,000
91,821,000
99,703,000
101,124,000
96,706,000
98,232,000
69,035,000
73,129,000
50,639,000
51,209,000
51,625,000
53,783,000
50,846,000
51,067,000
51,536,000
53,028,000
37,689,000
34,867,000
34,811,000
34,456,000
25,661,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.